Clinical Trials Directory

Trials / Completed

CompletedNCT01973634

Comparison of Acute Toxicity and Cost Between Whole Breast Irradiation With Sequential Boost and Simultaneous Integrated Boost After Breast Conserving Surgery.

Comparison of Acute Toxicity and Cost Between Whole Breast Irradiation With Sequential Boost and Simultaneous Integrated Boost After Breast Conserving Surgery

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
170 (actual)
Sponsor
University Hospital, Ghent · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

Whole breast irradiation (WBI) after breast conserving surgery for early-stage breast cancer halves the recurrence risk and reduces the breast cancer death by about one sixth. A sequential boost (SeqB) dose to the tumour bed further improves local control, but also increases the risk of late skin toxicity and cosmetic changes. At Ghent University Hospital WBI is prescribed in 15 fractions of 2.67 Gy according to the START-B hypofractionation scheme. A sequential boost is typically given in 4 to 8 extra fractions which prolongs the overall treatment time. The boost dose can also be delivered within the 15 fractions of WBI, the so-called simultaneous integrated boost (SIB). SIB shortens the overall treatment time which is convenient for the patient and the radiotherapy department. In this study we wish to test the hypothesis of acceptable skin toxicity and reduced cost with SIB using hypofractionated prone intensity modulation radiotherapy IMRT with topographical dose painting, a technique recently developed in our group. Patients are randomized between SeqB and SIB.

Conditions

Interventions

TypeNameDescription
RADIATIONsequential boost (15 x 2.67 Gy WBI + 4 x 2.5 Gy boost)Minimal surgical margin of 1 mm, conventional arm with sequential boost (15 x 2.67 Gy WBI + 4 x 2.5 Gy boost)
RADIATIONSIB (15 x 2.67 Gy WBI and SIB 15 x 2.67-3.12 Gy)Minimal surgical margin of 1 mm, experimental arm with SIB (15 x 2.67 Gy WBI and SIB 15 x 2.67-3.12 Gy)
RADIATIONsequential boost (15 x 2.67 Gy WBI + 6 x 2.48 Gy boost)Minimal surgical margin \< 1 mm, conventional arm with sequential boost (15 x 2.67 Gy WBI + 6 x 2.48 Gy boost)
RADIATIONSIB (15 x 2.67 Gy WBI and SIB 15 x 2.67-3.33 Gy)Minimal surgical margin \< 1 mm, experimental arm with SIB (15 x 2.67 Gy WBI and SIB 15 x 2.67-3.33 Gy)

Timeline

Start date
2012-12-01
Primary completion
2015-12-01
Completion
2021-03-01
First posted
2013-10-31
Last updated
2022-12-02

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT01973634. Inclusion in this directory is not an endorsement.